BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Abbott Laboratories (ABT) and AbbVie (ABBV) Named to S&P Dividend Aristocrats Indices


1/22/2013 9:19:33 AM

ABBOTT PARK, Ill., Jan. 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) has once again been named to the S&P 500 Dividend Aristocrats and S&P High Yield Dividend Aristocrats Indices.

The S&P 500 Dividend Aristocrats comprises companies in the S&P 500 that have increased dividends every year for the past 25 consecutive years. The S&P High Yield Dividend Aristocrats includes companies within the S&P Composite 1500 with 20 straight years of dividend increases. Abbott has increased its dividend payout for 40 consecutive years.

Abbott's former research-based pharmaceutical business, which became the independent biopharmaceutical company AbbVie on Jan. 1, 2013, was also named to both lists based on the history of the combined companies' dividend record.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

SOURCE Abbott



Read at BioSpace.com

AbbVie
Abbott
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->